SCHEMBL5144774

SCHEMBL5144774

COc1ccc(C(O)C(=O)O)c(O)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.51
RAB9A P51151 2/20 0.51
HPGD P15428 3/20 0.50
ALDH1A1 P00352 2/20 0.50
MAPK1 P28482 2/20 0.50
TYR P14679 2/20 0.50
CYP3A4 P08684 2/20 0.50
BCHE P06276 1/20 0.50
ACHE P22303 1/20 0.50
TSHR P16473 2/20 0.49
BLM P54132 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
CYP1A2 P05177 3/20 0.47
LMNA P02545 3/20 0.47
PGR P06401 2/20 0.47
SLC6A2 P23975 2/20 0.47
CYP2C19 P33261 2/20 0.47
POLB P06746 1/20 0.47
CYP2D6 P10635 1/20 0.47
PDE4A P27815 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9988676 0.86 TSHR (0.53) NPC1RAB9AHPGDALDH1A1MAPK1
SCHEMBL9988677 0.86 TSHR (0.53) NPC1RAB9AHPGDALDH1A1MAPK1
SCHEMBL10318373 0.83 HTT (0.46) TSHRBLMNPSR1CYP1A2HTT
SCHEMBL10317018 0.83 HTT (0.46) TSHRBLMNPSR1CYP1A2HTT
SCHEMBL5462394 0.81 AKR1C3 (0.44) TSHRBLMNPSR1CYP1A2PTGS2
SCHEMBL5037803 0.81 NPC1 (0.50) NPC1RAB9AHPGDALDH1A1MAPK1
SCHEMBL10318321 0.81 PTGS2 (0.46) TSHRCYP1A2CYP2C19PTGS2AKR1C3
SCHEMBL10318257 0.81 PTGS2 (0.46) TSHRCYP1A2CYP2C19PTGS2AKR1C3
SCHEMBL11106833 0.80 HSD17B10 (0.47) TYRBCHEACHETSHRCYP1A2
SCHEMBL9662938 0.80 ALDH1A1 (0.51) NPC1RAB9AHPGDALDH1A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1992018116-A1 COMPOSITIONS COMPRISING 2-HYDROXYCARBOXYLIC ACIDS AND RELATED COMPOUNDS, AND METHODS FOR ALLEVIATING SIGNS OF DERMATOLOGICAL AGING YU RUEY J (US) 1992-10-29 WO claimed
EP-0273202-A2 Use of hydroxycarboxylic acids to enhance therapeutic effects of topical compositions for fungal infections and pigmented spots. Van Scott, Eugene J., Dr. (US) 1988-07-06 EP claimed
EP-1633368-A4 FOAMABLE PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATING A DISORDER STIEFEL LABORATORIES (US) 2007-03-14 EP disclosed
EP-1633368-A2 FOAMABLE PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATING A DISORDER STIEFEL LABORATORIES, INC. (US) 2006-03-15 EP disclosed
WO-2004105702-A2 FOAMABLE PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATING A DISORDER STIEFEL LABORATORIES, INC. (US) 2004-12-09 WO disclosed
US-4163759-A Process for preparing aromatic hydroxyaldehydes HAARMANN & REIMER GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1979-08-07 US disclosed